| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.043 | 0.8 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |